The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy
about
Prokineticins: new regulatory peptides in human reproductionGene-gene interactions and gene polymorphisms of VEGFA and EG-VEGF gene systems in recurrent pregnancy lossThe anti-tumor effect is enhanced by simultaneously targeting VEGF and PROK1 in colorectal cancerPrognosis Relevance of Serum Cytokines in Pancreatic Cancer.Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical TumorsGenomic and epigenomic alterations in prostate cancer.Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes.Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: a cross sectional study.Expression of prokineticin-receptor2(PK-R2) is a new prognostic factor in human colorectal cancer.The prognosis was poorer in colorectal cancers that expressed both VEGF and PROK1 (No correlation coefficient between VEGF and PROK1).A Common Variant of PROK1 (V67I) Acts as a Genetic Modifier in Early Human Pregnancy through Down-Regulation of Gene Expression.The prokineticins: a novel pair of regulatory peptides.Potential roles of the prokineticins in reproductionVascular endothelial growth factor (VEGF) expression in locally advanced prostate cancer: secondary analysis of radiation therapy oncology group (RTOG) 8610.Prokineticin 2/Bv8 is expressed in Kupffer cells in liver and is down regulated in human hepatocellular carcinoma.Prokineticins and Merkel cell polyomavirus infection in Merkel cell carcinoma.Endocrine Gland-Derived Vascular Endothelial Growth Factor/Prokineticin-1 in Cancer Development and Tumor Angiogenesis.Prokineticin receptor 1 (PKR1) signalling in cardiovascular and kidney functions.PSMA, EpCAM, VEGF and GRPR as imaging targets in locally recurrent prostate cancer after radiotherapy.Expression of RIZ1 protein (Retinoblastoma-interacting zinc-finger protein 1) in prostate cancer epithelial cells changes with cancer grade progression and is modulated in vitro by DHT and E2.Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) and its receptor PROKR2 are associated to human colorectal cancer progression and peritoneal carcinomatosis.Anti-prokineticin1 (PROK1) monoclonal antibody suppresses angiogenesis and tumor growth in colorectal cancer.
P2860
Q26823052-6CC6D441-864A-47E3-9C9C-659DA91F176DQ33722070-BB65A4C0-2ECD-499F-9ABE-26D9BA509733Q35742461-40A5197F-5289-462B-84C0-D61309226D9AQ35963911-4A3E5946-5D8C-430B-BCC2-5EB077F2652AQ36240937-E9BE4E62-7DE4-424F-B5FC-CB168AD4527AQ36374578-6FB8CA27-DAC0-4929-8C04-B624FF304D98Q36415163-113B1B74-3FE7-42A6-9930-A09FF3E12FCBQ36487400-73428FEC-6E78-4356-B87B-A409E44E5C40Q36544678-2BB958AD-6D0E-45CC-9F55-63D91FFF2336Q36557136-17BCCED3-F782-4AF0-A201-CBB40AAAEA40Q36666959-0F03C6AA-6127-45BC-8629-A91367ADF32CQ36698041-252193BD-0C0E-4648-A3A2-D3CEB8C97B94Q36701614-E047D556-00E3-4244-91BF-DC5FB88C480CQ36843454-D8DE3535-E772-422F-AD1A-BA6942455899Q37212927-ABE86F66-2B43-4DAD-93F3-9519D4E4B592Q37650615-E81D485D-AE96-46A5-B682-7E1224F92020Q37721103-9751F45B-C785-4CAE-A7FE-508308A7FEECQ37920474-75CD8503-2E3B-4D48-A65D-7B3A2B67C7BDQ39357182-216A9FF1-9828-4CD2-820B-E73F8D935B0BQ39800864-25CAB554-9415-4AE0-BD72-CF340C22A911Q47308995-A5830D5D-1818-4B7A-9B43-F82B27DD659CQ53549011-A2D30802-3A60-4E18-919B-01A5F4433155
P2860
The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/prokineticin 1 and 2 and receptor expression in human prostate: Up-regulation of EG-VEGF/prokineticin 1 with malignancy
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The endocrine-gland-derived va ...... prokineticin 1 with malignancy
@ast
The endocrine-gland-derived va ...... prokineticin 1 with malignancy
@en
The endocrine-gland-derived va ...... prokineticin 1 with malignancy
@nl
type
label
The endocrine-gland-derived va ...... prokineticin 1 with malignancy
@ast
The endocrine-gland-derived va ...... prokineticin 1 with malignancy
@en
The endocrine-gland-derived va ...... prokineticin 1 with malignancy
@nl
prefLabel
The endocrine-gland-derived va ...... prokineticin 1 with malignancy
@ast
The endocrine-gland-derived va ...... prokineticin 1 with malignancy
@en
The endocrine-gland-derived va ...... prokineticin 1 with malignancy
@nl
P2093
P356
P1433
P1476
The endocrine-gland-derived va ...... prokineticin 1 with malignancy
@en
P2093
Antonio Agostino Sinisi
Antonio Bellastella
Daniela Pasquali
Domenico Prezioso
Donatella Tramontano
Gaetano De Rosa
Massimo Mascolo
Paolo Chieffi
Stefania Staibano
Valentina Rossi
P304
P356
10.1210/EN.2006-0614
P407
P577
2006-09-01T00:00:00Z